LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma

KeShan Wang1,2, TianBo Xu1,2, HaiLong Ruan1,2

  • 1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Cell Death & Disease
|February 17, 2019
PubMed

Insights

Liver X receptor alpha (LXRα) promotes renal cell carcinoma (RCC) metastasis by suppressing the NLRP3 inflammasome. LXRα may serve as a novel biomarker and therapeutic target for RCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Current renal cell carcinoma (RCC) treatments face limitations due to side effects and biomarker applicability.
  • Liver X receptors (LXRs) and the NLRP3 inflammasome are emerging research areas with potential clinical relevance.

Purpose of the Study:

  • To investigate the roles of Liver X receptor alpha (LXRα) and the NLRP3 inflammasome in renal cell carcinoma (RCC).
  • To explore the potential of LXRα as a diagnostic and prognostic biomarker and therapeutic target in RCC.

Main Methods:

  • Bioinformatics analysis
  • Molecular biology experiments
  • Biological function experiments

Main Results:

  • Elevated LXRα expression correlates with poor prognosis in RCC patients.
  • The expression levels and functions of the NLRP3 inflammasome in RCC were elucidated for the first time.
  • LXRα was found to promote RCC cell metastasis by suppressing NLRP3 inflammasome expression.

Conclusions:

  • LXRα shows potential as a novel diagnostic and prognostic biomarker for RCC.
  • Targeting LXRα may offer a new therapeutic strategy for managing RCC metastasis.
  • LXRα regulates RCC metastasis through its interaction with the NLRP3 inflammasome.

Related Concept Videos

pH Regulation in Cells01:28

pH Regulation in Cells

pH plays a critical role in maintaining normal cellular activities. It helps maintain the structure and function of various proteins, dictates the charge on cellular membranes, and is crucial for metabolic reactions inside the cell. Moreover, cells use the energy from the proton motive force to generate ATP.
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
7.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K